STELLARIS: A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Cenicriviroc for the Treatment of Liver Fibrosis in Adult Subjects with Nonalcoholic Steatohepatitis

  • Hodge, Alex, (Primary Chief Investigator (PCI))

Project: Research

Project Description

NMA HREC Reference Number: HREC/17/QRBW/128
NMA SSA Reference Number: SSA/17/MonH/382
Monash Health Ref: RES-17-0000440X
StatusActive
Effective start/end date5/09/194/09/24

Keywords

  • phase 3 study
  • hepatitis
  • treatment efficacy
  • clinical trial